{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:32:50Z","timestamp":1789162370719,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T00:00:00Z","timestamp":1340409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00277-012-1508-0","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T23:00:07Z","timestamp":1342911607000},"page":"1741-1745","source":"Crossref","is-referenced-by-count":34,"title":["Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas"],"prefix":"10.1007","volume":"91","author":[{"given":"Tung-Liang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Yung","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzung-Chih","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,23]]},"reference":[{"key":"1508_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235\u2013242","journal-title":"N Engl J Med"},{"key":"1508_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","volume":"7","author":"M Pfreundschuh","year":"2006","unstructured":"Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, Gill D, Walewski J, Zinzani PL, Stahel R, Kvaloy S, Shpilberg O, Jaeger U, Hansen M, Lehtinen T, Lopez-Guillermo A, Corrado C, Scheliga A, Milpied N, Mendila M, Rashford M, Kuhnt E, Loeffler M (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379\u2013391","journal-title":"Lancet Oncol"},{"key":"1508_CR3","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"W Hiddemann","year":"2005","unstructured":"Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, Reiser M, Metzner B, Harder H, Hegewisch-Becker S, Fischer T, Kropff M, Reis HE, Freund M, Wormann B, Fuchs R, Planker M, Schimke J, Eimermacher H, Trumper L, Aldaoud A, Parwaresch R, Unterhalt M (2005) Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 106:3725\u20133732","journal-title":"Blood"},{"key":"1508_CR4","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, Lepeu G, Plantier I, Castaigne S, Lefort S, Marit G, Macro M, Sebban C, Belhadj K, Bordessoule D, Ferme C, Tilly H (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood 116:2040\u20132045","journal-title":"Blood"},{"key":"1508_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbmt.2007.11.013","volume":"14","author":"T Seshadri","year":"2008","unstructured":"Seshadri T, Kuruvilla J, Crump M, Keating A (2008) Salvage therapy for relapsed\/refractory diffuse large B cell lymphoma. Biol Blood Marrow Transplant 14:259\u2013267","journal-title":"Biol Blood Marrow Transplant"},{"key":"1508_CR6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bmt.1701624","volume":"23","author":"CH Moskowitz","year":"1999","unstructured":"Moskowitz CH, Nimer SD, Glassman JR, Portlock CS, Yahalom J, Straus DJ, O\u2019Brien JP, Elkin N, Bertino JR, Zelenetz AD (1999) The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma. Bone Marrow Transplant 23:561\u2013567","journal-title":"Bone Marrow Transplant"},{"key":"1508_CR7","first-page":"3562","volume":"92","author":"J Blay","year":"1998","unstructured":"Blay J, Gomez F, Sebban C, Bachelot T, Biron P, Guglielmi C, Hagenbeek A, Somers R, Chauvin F, Philip T (1998) The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group Blood 92:3562\u20133568","journal-title":"Parma Group. Blood"},{"key":"1508_CR8","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","volume":"28","author":"C Gisselbrecht","year":"2010","unstructured":"Gisselbrecht C, Glass B, Mounier N, Singh Gill D, Linch DC, Trneny M, Bosly A, Ketterer N, Shpilberg O, Hagberg H, Ma D, Briere J, Moskowitz CH, Schmitz N (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 28:4184\u20134190","journal-title":"J Clin Oncol"},{"key":"1508_CR9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/annonc\/mdl049","volume":"17","author":"M Liedtke","year":"2006","unstructured":"Liedtke M, Hamlin PA, Moskowitz CH, Zelenetz AD (2006) Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Ann Oncol 17:909\u2013913","journal-title":"Ann Oncol"},{"key":"1508_CR10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00277-010-1044-8","volume":"90","author":"N Goldschmidt","year":"2011","unstructured":"Goldschmidt N, Or O, Klein M, Savitsky B, Paltiel O (2011) The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma. Ann Hematol 90:165\u2013171","journal-title":"Ann Hematol"},{"key":"1508_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/10428194.2011.639882","volume":"53","author":"GA Abel","year":"2012","unstructured":"Abel GA, Vanderplas A, Rodriguez MA, Crosby AL, Czuczman MS, Niland JC, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, Lacasce AS (2012) High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database. Leuk Lymphoma 53:1113\u20131116","journal-title":"Leuk Lymphoma"},{"key":"1508_CR12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1200\/JCO.1991.9.7.1196","volume":"9","author":"JC Weeks","year":"1991","unstructured":"Weeks JC, Yeap BY, Canellos GP, Shipp MA (1991) Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol 9:1196\u20131203","journal-title":"J Clin Oncol"},{"key":"1508_CR13","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17:1244\u20131253","journal-title":"J Clin Oncol"},{"key":"1508_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/1042819021000040323","volume":"44","author":"AE Guppy","year":"2003","unstructured":"Guppy AE, Tebbutt NC, Norman A, Cunningham D (2003) The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin\u2019s lymphoma. Leuk Lymphoma 44:123\u2013125","journal-title":"Leuk Lymphoma"},{"key":"1508_CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.10017","volume":"69","author":"A Elis","year":"2002","unstructured":"Elis A, Blickstein D, Klein O, Eliav-Ronen R, Manor Y, Lishner M (2002) Detection of relapse in non-Hodgkin\u2019s lymphoma: role of routine follow-up studies. Am J Hematol 69:41\u201344","journal-title":"Am J Hematol"},{"key":"1508_CR16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00006231-200211000-00007","volume":"23","author":"B Bossche Van Den","year":"2002","unstructured":"Van Den Bossche B, Lambert B, De Winter F, Kolindou A, Dierckx RA, Noens L, Van De Wiele C (2002) 18FDG PET versus high-dose 67\u00a0Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Nucl Med Commun 23:1079\u20131083","journal-title":"Nucl Med Commun"},{"key":"1508_CR17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/cncr.10336","volume":"94","author":"L Kostakoglu","year":"2002","unstructured":"Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ (2002) Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Cancer 94:879\u2013888","journal-title":"Cancer"},{"key":"1508_CR18","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1200\/JCO.2005.01.891","volume":"23","author":"ME Juweid","year":"2005","unstructured":"Juweid ME, Wiseman GA, Vose JM, Ritchie JM, Menda Y, Wooldridge JE, Mottaghy FM, Rohren EM, Blumstein NM, Stolpen A, Link BK, Reske SN, Graham MM, Cheson BD (2005) Response assessment of aggressive non-Hodgkin\u2019s lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 23:4652\u20134661","journal-title":"J Clin Oncol"},{"key":"1508_CR19","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/annonc\/mdq215","volume":"21","author":"CA Thompson","year":"2010","unstructured":"Thompson CA, Charlson ME, Schenkein E, Wells MT, Furman RR, Elstrom R, Ruan J, Martin P, Leonard JP (2010) Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol 21:2262\u20132266","journal-title":"Ann Oncol"},{"key":"1508_CR20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/annonc\/mdl099","volume":"17","author":"JO Armitage","year":"2006","unstructured":"Armitage JO, Loberiza FR (2006) Is there a place for routine imaging for patients in complete remission from aggressive lymphoma? Ann Oncol 17:883\u2013884","journal-title":"Ann Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1508-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1508-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1508-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:50:26Z","timestamp":1559022626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1508-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,23]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1508"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1508-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,23]]}}}